Moreover, the higher enrichment of resting memory CD4 + T cells in the CRG and immune high-risk subgroups implies that their activation, proliferation, and differentiation into specific Th subsets may offer new insights into the pathogenesis and therapy for gliomas [37]. Here, CD4 is linked to glioma.